Education and Applied Research Activity in Health Economics
Commissioned by KEPP · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Proposal for structuring categories and enriching the “HEALTH” subsystem with indicators on the Gnomon Analysis Data Platform
Commissioned by GNOMON ANALYSIS · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
European Joint Action to maximise the impact of the EU global health strategy
Commissioned by the European Commission · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Multi-Criteria Decision Analysis for Resource Allocation and Priority Setting in Health Systems
Co-funded action under the NSRF (ESPA) · Research Centre of the University of Piraeus
Unmet Medical Needs
Commissioned by HUMANE · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Identification and analysis of the key attributes contributing to treatment non-adherence in patients with neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DME)
Commissioned by Roche (Hellas) S.A. · Implemented by the Laboratory of Health Economics and Management
The integration of pharmaceutical innovation into the modern health system
Commissioned by Roche (Hellas) S.A. · Implemented by the Laboratory of Health Economics and Management
The benefits of introducing innovation into the health system
Commissioned by Roche (Hellas) S.A. · Implemented by the Laboratory of Health Economics and Management
HyQvia® — Construction of an HTA dossier for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
Commissioned by Takeda Hellas S.A. · Implemented by the Laboratory of Health Economics and Management
Determination of needs and costing of medical biopathology laboratories in Greece
Commissioned by E.E.P.A. · Implemented by the Laboratory of Health Economics and Management
Innovative therapies and their integration into everyday practice: opportunities, challenges and prospects
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Opdivo Neoadjuvant NSCLC (Non-Small Cell Lung Cancer)
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Preparation of an application to the HTA Committee for the reimbursement of Zeposia (ozanimod) for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS)
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Support for local data collection for the adaptation of the CEM and BIM of Zeposia (ozanimod) for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS)
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
The value of immuno-oncology for the patient, the health system and society
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Preparation of an application to the HTA Committee for the reimbursement of Opdivo in second-line unresectable advanced, recurrent or metastatic oesophageal squamous cell carcinoma (ESCC)
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
HTA application for the reimbursement of Entyvio for the treatment of Crohn’s disease and ulcerative colitis
Commissioned by Takeda Hellas S.A. · Implemented by the Laboratory of Health Economics and Management
Assessment and reimbursement of Opdivo plus Yervoy for the first-line treatment of non-small cell lung cancer (NSCLC)
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Parameterisation of the Budget Impact Model and Analysis in the Greek setting from the EOPYY perspective for Adcetris in the first line of treatment for Hodgkin lymphoma
Commissioned by Takeda Hellas S.A. · Implemented by the Laboratory of Health Economics and Management
Assessment of the safety and efficacy data of monoclonal antibodies in migraine
Commissioned by Roche (Hellas) S.A. · Implemented by the Laboratory of Health Economics and Management
Subcutaneous administration of antineoplastic therapies
Commissioned by Roche (Hellas) S.A. · Implemented by the Laboratory of Health Economics and Management
Satellite Meeting IFLA WLIC 2019 Athens
Commissioned by KEPP · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Operational needs of the Laboratory of Health Economics and Management (LabHEM)
Commissioned by KEPP · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Policy paper “Ask the Right Question about Lung Cancer”
Commissioned by FAIRLIFE Lung Cancer Care · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
The assessment and reimbursement of pharmaceutical innovation: the case of immunotherapy
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
The benefits of subcutaneous forms of treatment for the health system
Commissioned by Roche (Hellas) S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Assessment of innovative routes of administration and their contribution to the health system
Commissioned by Roche (Hellas) S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
The benefits of subcutaneous forms of treatment for the health system
Commissioned by Roche (Hellas) S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Assessment of innovative routes of administration and their contribution to the health system
Commissioned by Roche (Hellas) S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
The assessment and reimbursement of immunotherapy in lung cancer
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Challenges in the journey of the oncology patient from breast cancer diagnosis
Commissioned by Roche (Hellas) S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Challenges in public hospital pharmaceutical expenditure
Commissioned by Roche (Hellas) S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
The benefit of early therapeutic intervention for the health system
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Key problems of the National Health System and of the insured, and the transformation of EOPYY: observations and proposals
Commissioned by the Supreme General Confederation of Pensioners of Greece (A.G.S.S.E.) · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Local data collection for CEM/BIM adaptation and HTA application completion in Greece for renal cell carcinoma (RCC)
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Local data collection for CEM/BIM adaptation in Greece for colorectal cancer
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Local data collection for CEM/BIM adaptation and HTA application completion in Greece for mesothelioma
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Decision support system under uncertainty for the legal and economic management of civil medical liability cases
Funded by the Ministry of National Education and Religious Affairs · Research Centre of the University of Piraeus · Implemented by Associate Professor Athanassios Vozikis
Scientific study investigating the causes of delay in the diagnosis and initiation of treatment of cancer patients
Commissioned by the Hellenic Cancer Federation (ELLOK) · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Scientific study investigating the causes of delay in the initiation of radiotherapy for cancer patients
Commissioned by the Hellenic Cancer Federation (ELLOK) · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
HTA dossier preparation and Global Value dossier adaptation for Greece of oral GLP-1RA for the treatment of diabetes
Commissioned by Novo Nordisk Hellas Ltd. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Assessment and reimbursement of Opdivo plus Yervoy for the first-line treatment of non-small cell lung cancer (NSCLC)
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Preparation of an application to the HTA Committee for the reimbursement of Opdivo in second-line unresectable advanced, recurrent or metastatic oesophageal squamous cell carcinoma (ESCC)
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Support for the local adaptation of the cost-effectiveness and budget impact models of Opdivo (nivolumab) in the treatment of advanced oesophageal cancer
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
HTA application for the reimbursement of Adcetris for the treatment of systemic anaplastic large cell lymphoma (sALCL)
Commissioned by Takeda Hellas S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Development of an incentive framework for the recruitment and retention of doctors and other health professionals in the island regions of Greece
National and Kapodistrian University of Athens, Department of Nursing, Public Health Sector, Laboratory for the Organisation and Assessment of Health Services
Subcutaneous formulations in the health system
Commissioned by Roche (Hellas) S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Advisory support on the assessment and reimbursement of immunotherapy in cancer care
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Assessment of the safety and efficacy data of monoclonal antibodies in migraine
Commissioned by Pharmabide Ltd. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Subcutaneous administration of antineoplastic therapies
Commissioned by Roche (Hellas) S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
The contribution of physical activity and exercise to improving health and wellbeing
Funded by various bodies · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Parameterisation of the Budget Impact Model and Analysis in the Greek setting from the EOPYY perspective for Adcetris in the first line of treatment for Hodgkin lymphoma
Commissioned by Takeda Hellas S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Pharmaceutical expenditure, assessment and negotiations on new innovative therapies
Commissioned by Roche Hellas · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Management of the resources of the Central Library of the University of Piraeus
Funded by various bodies · Research Centre of the University of Piraeus · Implemented by Associate Professor Athanassios Vozikis
Advisory support to executives of Bristol-Myers Squibb S.A. on the economic evaluation of innovative therapies
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Advisory support to executives of Bristol-Myers Squibb S.A. on the economic evaluation of innovative therapies
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Advisory support to executives of Bristol-Myers Squibb S.A. on the economic evaluation of innovative therapies
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Satellite Meeting IFLA WLIC 2019 Athens
Funded by various bodies · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Advisory support to executives of Bristol-Myers Squibb S.A. on the economic evaluation of innovative therapies (second period)
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Advisory support to executives of Bristol-Myers Squibb S.A. on the economic evaluation of innovative therapies (first period)
Commissioned by Bristol-Myers Squibb S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Advisory support to executives of LEO Pharmaceutical S.A. on the economic evaluation and negotiation of medicines
Commissioned by LEO Pharmaceutical S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
2nd Panhellenic Conference on Technology, Economics and Management, “The development of the health sector: new applications, policies and challenges”
Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Advisory support to executives of Astellas Pharmaceuticals on negotiation strategies and reimbursement agreements for pharmaceutical products
Commissioned by Astellas Pharmaceuticals · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Training of executives of Genesis Pharma S.A. in advanced pricing and market access
Commissioned by Genesis Pharma S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Scientific collaboration on negotiation strategies for pharmaceutical products
Commissioned by Pfizer Hellas S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Assessment of the organisational and ethical impact of the use of long-acting antibiotics for the management of infections
Commissioned by Università Carlo Cattaneo – LIUC, CREMS (Centre for Research on Health Economics, Social and Health Care Management) · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Training of executives of Specifar S.A. on negotiation strategies for pharmaceutical products
Commissioned by Specifar S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Training of the scientific associates of Merck, Sharp & Dohme
Commissioned by Merck, Sharp & Dohme · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Smoking in Greek Cinema (1948–2013)
Commissioned by the Union of Kiosk Professionals of Piraeus and Surrounding Areas “Agia Trias” · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Training of executives in advanced pricing and market access
Commissioned by Genesis Pharma S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Provision of advisory services on negotiation strategies for pharmaceutical products
Commissioned by Pfizer Hellas S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
Training of executives in Health Economics for Non-Economists
Commissioned by AbbVie Pharmaceuticals S.A. · Research Centre of the University of Piraeus · Implemented by the Laboratory of Health Economics and Management
